NFKB1 and metabolic dysfunction-associated steatotic liver disease: It is believed that the suppression of endoplasmic reticulum stress‐related biomarkers in the liver immune cells prevents the activation of inflammatory pathways including NF‐κB, and consequently NAFLD development (Xie et al., 2022).